BRUNELLI, Matteo
 Distribuzione geografica
Continente #
EU - Europa 24.566
NA - Nord America 24.123
AS - Asia 16.367
SA - Sud America 2.448
AF - Africa 572
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 15
Totale 68.139
Nazione #
US - Stati Uniti d'America 23.374
RU - Federazione Russa 9.433
SG - Singapore 6.336
CN - Cina 4.913
GB - Regno Unito 4.638
IT - Italia 3.182
BR - Brasile 1.929
VN - Vietnam 1.511
HK - Hong Kong 1.508
SE - Svezia 1.435
DE - Germania 1.432
IE - Irlanda 1.114
FR - Francia 1.113
FI - Finlandia 855
KR - Corea 545
CA - Canada 497
IN - India 281
NL - Olanda 265
UA - Ucraina 252
JP - Giappone 234
AR - Argentina 186
TR - Turchia 180
MX - Messico 157
BD - Bangladesh 153
ES - Italia 147
PL - Polonia 147
NG - Nigeria 126
BE - Belgio 118
ZA - Sudafrica 110
IQ - Iraq 106
ID - Indonesia 97
EC - Ecuador 82
AT - Austria 81
LT - Lituania 75
CO - Colombia 69
PK - Pakistan 64
TG - Togo 62
MA - Marocco 55
BJ - Benin 52
VE - Venezuela 52
SA - Arabia Saudita 45
CL - Cile 44
UZ - Uzbekistan 44
AU - Australia 41
CZ - Repubblica Ceca 40
PH - Filippine 36
PY - Paraguay 36
MY - Malesia 30
TN - Tunisia 29
AE - Emirati Arabi Uniti 28
EG - Egitto 27
JO - Giordania 27
KE - Kenya 27
IR - Iran 26
AZ - Azerbaigian 25
LV - Lettonia 21
CH - Svizzera 20
KZ - Kazakistan 20
DZ - Algeria 19
PT - Portogallo 19
AL - Albania 18
PE - Perù 17
RS - Serbia 17
JM - Giamaica 16
NP - Nepal 16
RO - Romania 16
GR - Grecia 15
IL - Israele 15
UY - Uruguay 15
BO - Bolivia 14
PA - Panama 14
PS - Palestinian Territory 14
BG - Bulgaria 13
DK - Danimarca 13
DO - Repubblica Dominicana 13
CI - Costa d'Avorio 12
SN - Senegal 12
HN - Honduras 11
HU - Ungheria 11
KG - Kirghizistan 10
LB - Libano 10
AM - Armenia 9
ET - Etiopia 9
HR - Croazia 9
LK - Sri Lanka 9
NO - Norvegia 9
BY - Bielorussia 8
CR - Costa Rica 8
EU - Europa 8
MD - Moldavia 8
OM - Oman 8
TH - Thailandia 8
TW - Taiwan 8
CY - Cipro 7
MT - Malta 7
SK - Slovacchia (Repubblica Slovacca) 7
SY - Repubblica araba siriana 7
AO - Angola 6
IM - Isola di Man 6
LA - Repubblica Popolare Democratica del Laos 6
Totale 68.009
Città #
Southend 3.738
Singapore 3.410
Moscow 3.169
Ashburn 2.877
Chandler 2.472
Dallas 2.150
San Jose 2.150
Hong Kong 1.483
Jacksonville 1.336
Dublin 1.100
Woodbridge 1.068
Beijing 981
Ann Arbor 960
Verona 910
The Dalles 758
New York 651
Los Angeles 560
Houston 509
Munich 487
Ho Chi Minh City 470
Lawrence 367
Princeton 367
Wilmington 345
Jinan 332
Hanoi 310
Helsinki 309
Nanjing 248
Shenyang 229
São Paulo 229
Tokyo 217
Buffalo 216
Milan 197
Montréal 195
Santa Clara 188
Council Bluffs 185
Rome 182
Mcallen 179
Columbus 176
Hebei 175
Tianjin 175
Redondo Beach 169
Orem 164
London 156
Turku 146
Montreal 137
Sindelfingen 134
Dearborn 131
Zhengzhou 127
Frankfurt am Main 122
Warsaw 120
Redmond 118
Abuja 115
Brussels 113
Seattle 112
Seoul 110
Ningbo 106
Guangzhou 105
Changsha 104
Denver 102
Bologna 96
Boardman 94
Taizhou 94
Brooklyn 92
Stockholm 92
Chennai 90
Haikou 88
Amsterdam 85
Nanchang 80
Redwood City 74
Toronto 73
Atlanta 72
Chicago 72
Hangzhou 72
Johannesburg 70
Taiyuan 70
Mexico City 68
Jiaxing 66
Lancaster 66
San Francisco 65
Phoenix 64
Rio de Janeiro 63
Lomé 61
Poplar 61
Haiphong 60
Da Nang 59
Dong Ket 57
Manchester 54
Cotonou 52
Norwalk 52
Madrid 51
Boston 50
Volga 47
Belo Horizonte 46
Nuremberg 46
Vienna 46
Jakarta 44
Baghdad 43
Washington 41
Paris 40
Fairfield 39
Totale 41.106
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 900
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 665
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 372
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 326
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 313
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 285
Una complessa valutazione della vitalità delle fratture in ambito forense 271
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 257
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 255
Schwannoma del rene 254
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 253
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 247
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 247
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience 246
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 245
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 241
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 239
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 237
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 232
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 229
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 229
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 227
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 226
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 223
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 221
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 221
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 219
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 218
Consultation between forensic and clinical pathologists for histopathology examination after forensic autopsy 218
CD10 is expressed in a subset of chromophobe renal cell carcinomas 217
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 217
Chondroid syringoma with extensive ossification 217
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 216
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 215
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 215
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 214
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 214
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 214
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 214
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 212
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 211
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 210
Autophagy pathways in drug abusers after forensic autopsy: LC3B, ph-mTOR and p70S6K analysis 210
Adenocarcinoma of the paraurethral glands: a case report 209
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 209
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 209
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 207
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 207
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 205
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 204
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 202
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 200
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 200
Liver Metastases From Renal Oncocytoma With Vascular Extension 200
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 200
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 200
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 200
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 199
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 198
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 198
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 198
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 198
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 197
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 197
A pseudotumoral lesion diagnosed for a hypertrofic fibrosis at the proximal stump in anterior tibialis tendon missed rupture: a case report 197
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 196
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 196
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 196
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 196
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 195
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 195
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 194
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 194
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 194
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 194
Extended pelvic lymphadenectomy for prostate cancer: should the cloquet's nodes dissection be considered only an option? 193
[Diagnostic and prognostic markers in renal tumors] 192
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 192
Consultation interface between Pathologist and Forensic Science Experts for histopathology examination 192
[Small cell carcinoma of the bladder. Report of 3 cases and review of the literature] 192
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 191
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 191
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 191
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 191
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 191
Diagnostic concordance between whole slide imaging and conventional light microscopy in cytopathology: A systematic review 191
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 188
Cortical Expression of the Polysialylated Isoform of the Neural Cell Adhesion Molecule on Brain Tissue to Recognize Drug-Related Death: An Exploratory Analysis 187
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 187
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury 187
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 186
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 186
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 186
Rapid screening for malignancy in organ donors. 15 years experience with the Verona "Alert" protocol and review of the literature 186
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 185
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 185
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 185
'Case of the Month' from the University of Verona, Italy-navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 185
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 184
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 184
Totale 22.404
Categoria #
all - tutte 221.811
article - articoli 202.056
book - libri 0
conference - conferenze 19.371
curatela - curatele 0
other - altro 384
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 443.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021736 0 0 0 0 0 0 0 0 0 62 416 258
2021/20223.076 333 739 51 338 150 132 50 208 93 85 232 665
2022/20237.040 459 772 615 1.188 606 1.737 72 482 765 72 162 110
2023/20244.081 172 300 332 447 481 669 199 246 67 279 638 251
2024/202510.130 507 544 549 1.656 428 351 579 448 1.428 687 983 1.970
2025/202630.862 2.061 1.614 2.351 5.587 8.304 2.120 2.688 1.643 2.697 1.797 0 0
Totale 69.067